1. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol. 2001. 28:113–119.
Article
2. Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol. 2003. 139:1181–1183.
Article
3. Choi MJ, Kim HS, Park HJ, Park CJ, Lee JD, Lee JY, et al. Clinicopathologic manifestations of 36 korean patients with acute generalized exanthematous pustulosis: a case series and review of the literature. Ann Dermatol. 2010. 22:163–169.
Article
4. Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest. 2001. 107:1433–1441.
Article
5. Goeschke B, Braathen LR. Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far. Dermatology. 2004. 209:53–56.
Article
6. Yang CC, Lee JY, Chen WC. Acute generalized exanthematous pustulosis caused by celecoxib. J Formos Med Assoc. 2004. 103:555–557.
7. Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol. 1968. 80:771–793.
8. Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (four cases) (author's transl). Ann Dermatol Venereol. 1980. 107:37–48.
9. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology. 2005. 209:209–216.
Article